Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Arrow - Latanoprost
Active Ingredient: Latanoprost 0.05mg/mL
Dosage Form: Eye drops, solution
New Zealand Sponsor: Arrow Pharmaceuticals (NZ) Limited
Manufacturers: Catalent Pharma Solutions LLC, Illinois, United States of America
SIFI S.p.A, Antonio, Italy
Product: Blackmores Flexagil Pain Relief Cream
Active Ingredient: Symphytum officinale 350mg/g
Dosage Form: Topical cream
New Zealand Sponsor: Blackmores (NZ) Limited
Manufacturer: Merck KGaA & Co, Spittal/Drau, Austria
Product: Exjade
Active Ingredient: Deferasirox 125mg
Dosage Form: Dispersible tablet
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Novartis Pharma Stein AG, Stein, Switzerland
Product: Exjade
Active Ingredient: Deferasirox 250mg
Dosage Form: Dispersible tablet
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Novartis Pharma Stein AG, Stein, Switzerland
Product: Exjade
Active Ingredient: Deferasirox 500mg
Dosage Form: Dispersible tablet
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Novartis Pharma Stein AG, Stein, Switzerland
Product: Meropenem Ranbaxy
Active Ingredient: Meropenem trihydrate 570mg equivalent to Meropenem 500mg
Dosage Form: Powder for injection
New Zealand Sponsor: Douglas Pharmaceuticals Limited
Manufacturer: Ranbaxy Laboratories Limited, Madhya Pradesh, India
Product: Meropenem Ranbaxy
Active Ingredient: Meropenem trihydrate 1140mg equivalent to Meropenem 1g
Dosage Form: Powder for injection
New Zealand Sponsor: Douglas Pharmaceuticals Limited
Manufacturer: Ranbaxy Laboratories Limited, Madhya Pradesh, India
Dated this 2nd day of February 2012.
DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).